Mats Wahlstrom

Insider Reports History

Entity
Individual
Location
500 Golden Ridge Road, Suite 100, Golden, Colorado
Signature
/s/ Sean Murphy, Attorney-in-Fact for Mats Wahlstrom
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mats Wahlstrom:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Coherus BioSciences, Inc. Director Common Stock 100K $167K $1.67 Feb 9, 2024 Leonard Capital, LLC
Coherus BioSciences, Inc. Director Common Stock 0 $0 $1.67 Feb 9, 2024 Direct
Coherus BioSciences, Inc. Director Stock Option (Right to Buy) 112K Jun 3, 2024 Direct
TriSalus Life Sciences, Inc. Director, 10%+ Owner Director stock option (right to buy) 15K Aug 13, 2024 Direct

Insider Reports Filed by Mats Wahlstrom

Symbol Company Period Transactions Value $ Form Type Date Filed Role
TLSI TriSalus Life Sciences, Inc. Aug 13, 2024 1 $0 4 Aug 21, 2024 Director, 10%+ Owner
CHRS Coherus BioSciences, Inc. Jun 3, 2024 1 $0 4 Jun 5, 2024 Director
CHRS Coherus BioSciences, Inc. Feb 9, 2024 2 $0 4 Feb 15, 2024 Director
CHRS Coherus BioSciences, Inc. Feb 1, 2024 4 $100K 4 Feb 5, 2024 Director
TLSI TriSalus Life Sciences, Inc. Aug 10, 2023 1 $0 4 Aug 14, 2023 Director, 10%+ Owner
TLSI TriSalus Life Sciences, Inc. Aug 10, 2023 0 $0 3 Aug 14, 2023 Director, 10%+ Owner
CHRS Coherus BioSciences, Inc. Jun 7, 2023 1 $0 4 Jun 9, 2023 Director
CHRS Coherus BioSciences, Inc. Feb 25, 2022 3 $179K 4 Mar 1, 2022 Director
CHRS Coherus BioSciences, Inc. Jan 7, 2022 1 $0 4/A Feb 11, 2022 Director